Antimicrobial Catheter Market Growth Prediction and Demand 2018 to 2026

Antimicrobial Catheter Market.jpg
Antimicrobial catheters are designed to protect patients from hospital acquired urinary tract infections (UTIs). Hospital-acquired or nosocomial urinary tract infections are initiated by using urinary catheters, which are inserted in urinary tract during the treatment of hospitalized patients. In case of urinary tract infection, which is associated with the catheters, the bacteria travel up to the bladder and cause infection. Most of the urinary tract infections occur due to the use of catheters made with non-ideal material. Use of non-ideal material can lead to colonization of microorganisms, which results into bacteriuria and infection. However, to overcome infections related to catheters, manufacturers are focusing on development of antimicrobial catheters with materials that are biocompatible, antimicrobial, and antifouling.

Get Exclusive Sample Report at: http://bit.ly/31OUaqh

Antimicrobial Catheter Market – Drivers

Increasing initiatives by research firms to develop safe-to-use catheters is expected to increase the antimicrobial catheter market share. For instance, in March 2019, researcher at Brown University announced the development of a new antibacterial coating for intravascular catheters, which is expected to prevent catheter-related bloodstream infections, the most common type of hospital-acquired infections.

Increasing incidences of Catheter Associated Urinary Tract Infections (CAUTI) is expected to boost growth of the antimicrobial catheter market. For instance, in April 2015, according to the research study results For Catheter Associated Urinary Tract Infection (CAUTI) And Antibiotics Sensitivity Pattern from Confirmed Cases of CAUTI in Tertiary Care Hospitals, published in Clinical Microbiological journal, out of 1380 catheterized patients, 34 developed CAUTI. The overall incidence was 4.59 per 1000 catheter days.

Antimicrobial Catheter Market- Restraints

However, product recall for antimicrobial catheters is a major issue, which is hampering the antimicrobial catheter market growth. For instance, in October 2018, the U.S. Food and Drug Administration (FDA) issued a product recall notices to Rochester Medical Corp. to recall its Magic3 Antibacterial Hydrophilic Intermittent Catheter, owing to misbranding (mislabeling) of the product. The product was labeled as an Antibacterial Hydrophilic Intermittent Catheter instead of an Antibacterial Intermittent Catheter (no hydrophilic coating).

Antimicrobial Catheter Market- Regional Analysis

On the basis of region, the global antimicrobial catheter market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to witness significant growth over the forecast period, owing to increasing cases of CAUTIs in the region. For instance, in June 2016, according to report published in Modern Healthcare, CAUTIs were a major cause of hospital-acquired infection in the US and incidences of these infections have increased in the recent past.

Furthermore, Europe is expected to witness significant growth in the market, owing to increasing product launches in this region. For instance, in April 2018, a urinary catheter coated with new bacteria resistant materials, developed by the University of Nottingham, received CE marking for use by hospitals in the U.K. and other countries in Europe. The devices were trialed in 6 hospitals across the U.K.

Ask For Discount Before Purchasing This Business Report @ http://bit.ly/2X0MUnR

Antimicrobial Catheter Market- Key Players

Key players operating in the antimicrobial catheter market include, C. R. Bard, Medtronic Plc., B. Braun Melsungen AG, Cook Medical, and Teleflex Incorporated.

Antimicrobial Catheter Market- Taxonomy

By Catheter Type

Central Venous Catheters
Urinary Catheters

By Material Type

Silver Alloys Catheters
Nitrofural-impregnated Catheters

By End User

Hospitals
Ambulatory Surgical Centers
Clinics
Others

By Region

North America
Europe
Asia Pacific
Latin America
Middle East
Africa

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.


Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702

Comments

Post a Comment

Popular posts from this blog

Why the Cold Pain Therapy is a Growing Payer Opportunity?

Image
Cold pain therapy is a therapeutic application of cold, used in the treatment of acute soft tissue injuries and to reduce the pain in post-operative condition in orthopedic surgeries, treatment of benign and malignant lesions, and in pain management. Cryotherapy can be applied topically (on the skin surface), surgically or percutaneously. This can also be used to treat various skin conditions such as oral mucositis and tumors in the liver, kidney, bones, breasts and lungs, skin tumors, skin tags, pre-cancerous skin moles, and injuries. Cryosurgery procedure involves use of extreme cold, produced with help of liquid nitrogen (or argon gas) to destroy abnormal tissues. According to the National Cancer Institute (NCI), cryosurgery is used for treatment of several types of cancers and some non-cancerous conditions. It is reported to be effective for treatment in early stage skin cancer, retinoblastoma, actinic keratosis, and cervical intraepithelial neoplasia. Accord...
Read more

Ursodeoxycholic Acid Market Shows Boosted Growth Rate 2018-2026 Estimated by Global Top Players

Image
Ursodeoxycholic acid (UDCA) is a bile acid taken as either a tablet or liquid to treat gallstones and to treat and prevent the progression of cystic fibrosis-related liver disorder. UDCA modifies the bile acid pool by decreasing levels of hydrophobic bile acids while increasing proportion of nontoxic hydrophilic bile acids. UDCA can delay development of gastroesophageal varices and progression to cirrhosis. Moreover it can improve long-term survival in patients with primary biliary cirrhosis. Significant improvement in liver health can be achieved during UDCA therapy in patients with intrahepatic cholestasis of pregnancy, primary sclerosing cholangitis, nonalcoholic fatty liver disease, cystic fibrosis-associated liver disease, total parenteral nutrition-induced cholestasis, graft related liver disease, and in some pediatric cholestatic liver diseases. The global ursodeoxycholic acid market size was valued at US$ 346.2 million in 2017, and is expected to witn...
Read more

Booms and Busts in Anatomic Pathology Market; Dynamics Trends Over The Time Discussed 2018-2026

Image
Anatomic pathology involves direct visualization of human tissue as gross examination as well as under a microscope for proper diagnosis of the disease or a pathological condition. Subtypes of anatomic pathology include surgical pathology, oral and maxillofacial pathology, cytopathology, molecular pathology, and forensic pathology. Procedures performed in anatomic pathology include gross examination, histopathology, immunohistochemistry, in situ hybridization, cryopathology, tissue cytogenetics, and others. Standard approach in anatomical pathology is microscopic examination of tissue samples with the help of one or more stains. Manufacturers have developed stains to identify and classify microorganisms in biopsy of tissue samples or excisional specimens. Various gram stains and acid-fast stains have applications in detection of bacteria and mycobacteria in tissue samples. Commercially available products include tissue processing systems, microtomes, cryostats, ...
Read more